{"id":"W4293558161","doi":"10.1016/j.eururo.2022.08.005","title":"Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Olaparib; Interquartile range; Prostate cancer; Internal medicine; Response Evaluation Criteria in Solid Tumors; Pembrolizumab; Oncology; Adverse effect; Cohort; Tolerability; Urology; Progressive disease; Cancer; Disease; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000707665,0.0002526874,0.0004171746,0.0001319266,0.0003232981,0.00003894159,0.0002729028,0.00001604614,0.0001996014],"category_scores_gemma":[0.00008252466,0.0001593404,0.00004952351,0.0003850727,0.0001640847,0.00006775169,0.0002155595,0.0005920227,0.00002786121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003730762,"about_ca_system_score_gemma":0.0004242758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001215114,"about_ca_topic_score_gemma":0.001160439,"domain_scores_codex":[0.996405,0.001308165,0.0005015201,0.0006606212,0.0006356566,0.0004890155],"domain_scores_gemma":[0.9987447,0.0002074764,0.0001980065,0.0005997177,0.0001177354,0.0001324237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07506275,0.004148088,0.9059882,0.00001525909,0.0006204876,0.003785641,0.006260098,0.0003916108,0.000083865,0.00000390362,0.0005777857,0.003062343],"study_design_scores_gemma":[0.08333366,0.0085444,0.9063854,0.00001449957,0.0003411931,0.00001219663,0.0003374582,0.00009361815,0.00001080641,0.000003613856,0.0007749405,0.0001482104],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924192,0.0005292127,0.000003293689,0.001412512,0.0001575631,0.003536282,0.0008961529,0.00004520932,0.001000558],"genre_scores_gemma":[0.9968615,0.0000492389,0.00001400085,0.0004376657,0.00006946161,0.0003781481,0.001297724,0.00005989605,0.0008323311],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008270912,"threshold_uncertainty_score":0.6497711,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02590916212518864,"score_gpt":0.3095457383498139,"score_spread":0.2836365762246253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}